APA (7th ed.) Citation

Cheng, Y., Sung, F., Muo, C., Hsu, C., Tsai, W., & Hsu, Y. (2024). Statin therapy and upper tract urothelial carcinoma risk in hyperlipidemic patients with chronic kidney disease and end-stage kidney disease, a population-based 17-year follow-up study. Renal Failure, 46(2), 1. https://doi.org/10.1080/0886022X.2024.2402508

Chicago Style (17th ed.) Citation

Cheng, Ya-Chi, Fung-Chang Sung, Chih-Hsin Muo, Chih-Cheng Hsu, Wen-Chen Tsai, and Yueh-Han Hsu. "Statin Therapy and Upper Tract Urothelial Carcinoma Risk in Hyperlipidemic Patients with Chronic Kidney Disease and End-stage Kidney Disease, a Population-based 17-year Follow-up Study." Renal Failure 46, no. 2 (2024): 1. https://doi.org/10.1080/0886022X.2024.2402508.

MLA (9th ed.) Citation

Cheng, Ya-Chi, et al. "Statin Therapy and Upper Tract Urothelial Carcinoma Risk in Hyperlipidemic Patients with Chronic Kidney Disease and End-stage Kidney Disease, a Population-based 17-year Follow-up Study." Renal Failure, vol. 46, no. 2, 2024, p. 1, https://doi.org/10.1080/0886022X.2024.2402508.